SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028190
Filing Date
2021-11-12
Accepted
2021-11-12 16:16:29
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 927165
2 ex31.htm EX-31 34665
3 ex32.htm EX-32 8876
  Complete submission text file 0001493152-21-028190.txt   5535587

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE age-20210930.xsd EX-101.SCH 39047
5 XBRL CALCULATION FILE age-20210930_cal.xml EX-101.CAL 66339
6 XBRL DEFINITION FILE age-20210930_def.xml EX-101.DEF 189939
7 XBRL LABEL FILE age-20210930_lab.xml EX-101.LAB 357217
8 XBRL PRESENTATION FILE age-20210930_pre.xml EX-101.PRE 282866
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 971887
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 211403719
SIC: 2834 Pharmaceutical Preparations